The pharmaceutical landscape for glucose is evolving, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this approach offers a simpler way to administer GLP-1 https://mariamjryw052117.newsbloger.com/41587214/glp-1-patches-a-new-approach-to-blood-sugar-treatment